$0.28 3%
COEP Stock Price vs. AI Score
Data gathered: July 23

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Coeptis Therapeutics

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer.

Coeptis Therapeutics
Price $0.28
Target Price Sign up
Volume 46,710
Market Cap $11M
Year Range $0.26 - $1.29
Dividend Yield 0%
Industry Biotechnology

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24000-3M-2.6M-0.084
Q4 '23000-3.8M-3.1M-0.110
Q3 '23000-6.3M-7.6M-0.230
Q2 '23000-3.1M-3.3M-0.143
Q1 '23000-8M-7.7M-0.390

Insider Transactions View All

DeSilva Tara filed to buy 30,466 shares at $0.6.
January 16 '24
DeSilva Tara filed to buy 32,266 shares at $0.6.
January 16 '24
Cogley Brian filed to buy 30,000 shares at $0.7.
January 17 '24
Mehalick David filed to buy 2,768,611 shares at $0.7.
January 9 '24
Mehalick David filed to buy 2,782,615 shares at $0.7.
January 9 '24

What is the Market Cap of Coeptis Therapeutics?

The Market Cap of Coeptis Therapeutics is $11M.

What is the current stock price of Coeptis Therapeutics?

Currently, the price of one share of Coeptis Therapeutics stock is $0.28.

How can I analyze the COEP stock price chart for investment decisions?

The COEP stock price chart above provides a comprehensive visual representation of Coeptis Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Coeptis Therapeutics shares. Our platform offers an up-to-date COEP stock price chart, along with technical data analysis and alternative data insights.

Does COEP offer dividends to its shareholders?

As of our latest update, Coeptis Therapeutics (COEP) does not offer dividends to its shareholders. Investors interested in Coeptis Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Coeptis Therapeutics?

Some of the similar stocks of Coeptis Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.